Founded
Address
Thomas McNerney & Partners LLC
One Stamford Plaza 263 Tresser Blvd 16th Floor
Suite 1600
Stamford, CT 06901
United States
Phone
Website
Recent investment activity
KANDO id: 3811
Corporate information
Registration country
Company type
Healthcare venture firm.Overview
Thomas, McNerney & Partners is a health care venture firm that invested in life science and medical technology companies at all stages of development. The Thomas, McNerney & Partners team has significant experience in helping entrepreneurs start companies, in providing growth capital to emerging companies and in undertaking restructuring transactions such as spin-outs, roll-ups and recapitalizations.Funding rounds
Investment preferences
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 34| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Asante Solutions Inc | Developing a disposable drug delivery system which initially will be used for insulin delivery for Type I diabetics. | N/A | |||
|
|
Atritech Inc | Developing an endovascular device to prevent neurological stroke in patients suffering from atrial fibrillation | N/A | |||
|
|
CAS Medical Systems Inc | Designer and manufacturer of innovative, non-invasive technologies and products vital to patient care in the most challenging clinical environments. | N/A | |||
|
|
Cebix Inc | Series B | ||||
|
|
Cebix Inc | N/A | ||||
|
|
Celator Pharmaceuticals | Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. | N/A | |||
|
|
Coley Pharmaceutical Group Inc | N/A | ||||
|
|
Galil Medical Ltd | N/A | ||||
|
|
InnoPharma LLC | Series A | ||||
|
|
Intuity Medical Inc | Series D | ||||
|
|
Intuity Medical Inc | Series D | ||||
|
|
NeuroTherapeutics Pharma Inc | N/A | ||||
|
|
Ocera Therapeutics Inc | Development of drugs to treat gastrointestinal diseases | N/A | |||
|
|
Oriel Therapeutics Inc | Develops and commercializes respiratory care drugs. | N/A | |||
|
|
OsteoBiologics Inc | Developer and manufacturer of bioabsorbable polymeric scaffolds, films, and related instrumentations. | N/A | |||
|
|
Quinnova Pharmaceuticals Inc | Series B | ||||
|
|
Quinnova Pharmaceuticals Inc | Series A | ||||
|
|
SG Biofuels | Series B | ||||
|
|
Tioga Pharmaceuticals Inc | Series B | ||||
|
|
Torax Medical Inc | Series D | ||||
|
|
Torax Medical Inc | Series B | ||||
|
|
Tranzyme Pharma | Drug discovery and development, focused on gastroenterology indications | N/A | |||
|
|
Tranzyme Pharma | Drug discovery and development, focused on gastroenterology indications | N/A | |||
|
|
Ventritex Inc | Supplied a line of products for high risk cardiac patients | N/A | |||
|
|
Virdante Pharmaceuticals Inc | A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. | N/A |